Clinical Trial Update: Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing efficacy and safety of EPA in patients with type 2 diabetes and hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• EPA (eicosapentaenoic acid)

Snippet

Sponsor: University of Ioannina | Conditions: Diabetes Type 2, Hypertriglyceridemia | Phase 4 | Status: UNKNOWN